Cargando…

Evaluation of carotid intima-media thickness and flow-mediated dilatation in middle-aged patients with nonalcoholic fatty liver disease

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) has a high prevalence in the general population and is the most common liver disease in Western countries. It is a feature of metabolic syndrome and is characterized by excessive accumulation of fat in the liver cells. METHODS: We examined 84 cons...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammadi, Afshin, Sedani, Homayoon Habibpour, Ghasemi-Rad, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3225348/
https://www.ncbi.nlm.nih.gov/pubmed/22140316
http://dx.doi.org/10.2147/VHRM.S26011
_version_ 1782217500826533888
author Mohammadi, Afshin
Sedani, Homayoon Habibpour
Ghasemi-Rad, Mohammad
author_facet Mohammadi, Afshin
Sedani, Homayoon Habibpour
Ghasemi-Rad, Mohammad
author_sort Mohammadi, Afshin
collection PubMed
description BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) has a high prevalence in the general population and is the most common liver disease in Western countries. It is a feature of metabolic syndrome and is characterized by excessive accumulation of fat in the liver cells. METHODS: We examined 84 consecutive middle-aged (under 45 years) patients with NAFLD and 65 control subjects matched for age, gender, and body mass index to determine carotid intima-media thickness (CIMT) and flow-mediated dilatation (FMD) in the brachial artery. RESULTS: There was a statistically significant difference between CIMT and percentage increase in FMD in the patient group (P = 0.002; r = 0.33) when compared with the control group (P = 0.97; r = 0.005). The mean ± standard deviation CMIT was 0.65 ± 0.09 mm in patients and 0.55 ± 0.07 mm in controls. This difference was statistically significant (P = 0.001). Mean FMD in patients was 6.4% and 15.7% in controls. This difference was statistically significant (P = 0.001). CONCLUSION: This study shows that pure NAFLD without metabolic syndrome in middle-aged subjects is strongly associated with morphological (CIMT) and physiological (FMD) changes. These findings may have an important role in increasing cardiovascular risk in these patients.
format Online
Article
Text
id pubmed-3225348
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-32253482011-12-02 Evaluation of carotid intima-media thickness and flow-mediated dilatation in middle-aged patients with nonalcoholic fatty liver disease Mohammadi, Afshin Sedani, Homayoon Habibpour Ghasemi-Rad, Mohammad Vasc Health Risk Manag Original Research BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) has a high prevalence in the general population and is the most common liver disease in Western countries. It is a feature of metabolic syndrome and is characterized by excessive accumulation of fat in the liver cells. METHODS: We examined 84 consecutive middle-aged (under 45 years) patients with NAFLD and 65 control subjects matched for age, gender, and body mass index to determine carotid intima-media thickness (CIMT) and flow-mediated dilatation (FMD) in the brachial artery. RESULTS: There was a statistically significant difference between CIMT and percentage increase in FMD in the patient group (P = 0.002; r = 0.33) when compared with the control group (P = 0.97; r = 0.005). The mean ± standard deviation CMIT was 0.65 ± 0.09 mm in patients and 0.55 ± 0.07 mm in controls. This difference was statistically significant (P = 0.001). Mean FMD in patients was 6.4% and 15.7% in controls. This difference was statistically significant (P = 0.001). CONCLUSION: This study shows that pure NAFLD without metabolic syndrome in middle-aged subjects is strongly associated with morphological (CIMT) and physiological (FMD) changes. These findings may have an important role in increasing cardiovascular risk in these patients. Dove Medical Press 2011 2011-11-07 /pmc/articles/PMC3225348/ /pubmed/22140316 http://dx.doi.org/10.2147/VHRM.S26011 Text en © 2011 Mohammadi et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Mohammadi, Afshin
Sedani, Homayoon Habibpour
Ghasemi-Rad, Mohammad
Evaluation of carotid intima-media thickness and flow-mediated dilatation in middle-aged patients with nonalcoholic fatty liver disease
title Evaluation of carotid intima-media thickness and flow-mediated dilatation in middle-aged patients with nonalcoholic fatty liver disease
title_full Evaluation of carotid intima-media thickness and flow-mediated dilatation in middle-aged patients with nonalcoholic fatty liver disease
title_fullStr Evaluation of carotid intima-media thickness and flow-mediated dilatation in middle-aged patients with nonalcoholic fatty liver disease
title_full_unstemmed Evaluation of carotid intima-media thickness and flow-mediated dilatation in middle-aged patients with nonalcoholic fatty liver disease
title_short Evaluation of carotid intima-media thickness and flow-mediated dilatation in middle-aged patients with nonalcoholic fatty liver disease
title_sort evaluation of carotid intima-media thickness and flow-mediated dilatation in middle-aged patients with nonalcoholic fatty liver disease
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3225348/
https://www.ncbi.nlm.nih.gov/pubmed/22140316
http://dx.doi.org/10.2147/VHRM.S26011
work_keys_str_mv AT mohammadiafshin evaluationofcarotidintimamediathicknessandflowmediateddilatationinmiddleagedpatientswithnonalcoholicfattyliverdisease
AT sedanihomayoonhabibpour evaluationofcarotidintimamediathicknessandflowmediateddilatationinmiddleagedpatientswithnonalcoholicfattyliverdisease
AT ghasemiradmohammad evaluationofcarotidintimamediathicknessandflowmediateddilatationinmiddleagedpatientswithnonalcoholicfattyliverdisease